Page 145 - Linkedin News Today

JJP Biologics has received a positive conclusion on the Clinical Trial Application assessment for a Phase I Study of a potential first-in-class anti-CD89 antagonist, JJP-1212 monoclonal antibody for

The DPC is the lead EU regulator for a number of major international tech firms, including Google, Meta, Microsoft, TikTok and OpenAI

CellEDIT uses FluidFM for precise nuclear CRISPR/Cas9 injection, boosting efficiency by controlling RNP amounts, preserving traits in edited CHO-K1 cells....

The DPC is the lead EU regulator for a number of major international tech firms, including Google, Meta, Microsoft…

The DPC is the lead EU regulator for a number of major international tech firms, including Google, Meta, Microsoft…

- Late-breaking abstract on extended follow-up data from the MATCH Phase 2 trial accepted for poster presentation - - Poster presentation on new data highlighting the Company's discovery

EQS-News: BRAIN Biotech AG / Key word(s): PersonnelBRAIN Biotech AG announces the appointment of Erik de Vries as Senior Business Development Director Enzymes 29.05.2024 / 09:00 CET/CESTThe issuer is solely responsible for the content of this announcement.BRAIN Biotech AG announces the appointment of Erik de Vries a...

He is Wole Soyinka for a reason..! In whatever endeavour we pursue in life, we inevitably encounter both victories and defeats. Losing, in essence, is not inhumane; however, harbouring bitterness in defeat is what I consider truly inhumane. Furthermore, just because someone has bested me in competition does not make…

The CEO behind Tesla and SpaceX, Elon Musk, known for his extensive activity on social media X, formerly Twitter, this time targets the professional network owned by Microsoft, 'LinkedIn', with a bold remark about the platform. Responding to a post by a user named Alex Cohen, Musk, wrote, "LinkedIn is so cringe it will make your toenails curl".

Only 12.8% of entry-level positions are offering remote or hybrid arrangements.